Susanne Marschner

Terumo BCT, Scientific Affairs

Research Area

Biography

Susanne Marschner has not added Biography.
If you are Susanne Marschner and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 19	2015

Other Publications

Article	Year
Riboflavin and ultraviolet light for pathogen reduction of murine cytomegalovirus in blood products. Transfusion\| PubMed ID: 25438832	2014
Ligation of human CD4 interferes with antigen-induced activation of primary T cells. Immunology letters\| PubMed ID: 12008044	2002
CXCR4 engagement is required for HIV-1-induced L-selectin shedding. Blood\| PubMed ID: 14576059	2004
A human CD4 monoclonal antibody for the treatment of T-cell lymphoma combines inhibition of T-cell signaling by a dual mechanism with potent Fc-dependent effector activity. Cancer research\| PubMed ID: 17942927	2007
Treatment with riboflavin and ultraviolet light prevents alloimmunization to platelet transfusions and cardiac transplants. Transplantation\| PubMed ID: 17998874	2007
Understanding loss of donor white blood cell immunogenicity after pathogen reduction: mechanisms of action in ultraviolet illumination and riboflavin treatment. Transfusion\| PubMed ID: 19682337	2009
Lack of antibody formation to platelet neoantigens after transfusion of riboflavin and ultraviolet light-treated platelet concentrates. Transfusion\| PubMed ID: 19694996	2009
White blood cell inactivation after treatment with riboflavin and ultraviolet light. Transfusion\| PubMed ID: 20529002	2010
The Mirasol Pathogen Reduction Technology system and quality of platelets stored in platelet additive solution. Blood transfusion = Trasfusione del sangue\| PubMed ID: 20671879	2010
Evaluation of Different Preparation Procedures of Pathogen Reduction Technology(MirasolÂ®)-Treated Platelets Collected by Plateletpheresis. Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie\| PubMed ID: 21076549	2009
Generation of neutrophil priming activity by cell-containing blood components treated with pathogen reduction technology and stored in platelet additive solutions. Transfusion\| PubMed ID: 21155831	2011
Inactivation of human white blood cells in platelet products after pathogen reduction technology treatment in comparison to gamma irradiation. Transfusion\| PubMed ID: 21155832	2011
In vivo viability of stored red blood cells derived from riboflavin plus ultraviolet light-treated whole blood. Transfusion\| PubMed ID: 21275998	2011
Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light. Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie\| PubMed ID: 21779202	2011
In vitro quality of single-donor platelets treated with riboflavin and ultraviolet light and stored in platelet storage medium for up to 8 days. Transfusion\| PubMed ID: 22014032	2012
The inositol 5-phosphatase SHIP-1 and adaptors Dok-1 and 2 play central roles in CD4-mediated inhibitory signaling. Immunology letters\| PubMed ID: 22370159	2012
Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-associated graft-versus-host disease? Transfusion\| PubMed ID: 22612327	2013
Development of a riboflavin and ultraviolet light-based device to treat whole blood. Transfusion\| PubMed ID: 23301965	2013
Immune modulation and lack of alloimmunization following transfusion with pathogen-reduced platelets in mice. Transfusion\| PubMed ID: 23451715	2013
Evaluation of the spectra Optia® mononuclear cell collection procedure in multiple myeloma patients. Journal of clinical apheresis\| PubMed ID: 24941931	2015
Observational study of corrected count increments after transfusion of platelets treated with riboflavin pathogen reduction technology in additive solutions. Transfusion\| PubMed ID: 25702711	2015
Inactivation of viruses in platelet and plasma products using a riboflavin-and-UV-based photochemical treatment. Transfusion\| PubMed ID: 25731607	2015
Transfusion of Human Platelets Treated with Mirasol Pathogen Reduction Technology Does Not Induce Acute Lung Injury in Mice. PloS one\| PubMed ID: 26176623	2015